Related references
Note: Only part of the references are listed.Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma
Naoki Ogane et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2010)
Radiotherapy or CO2 laser surgery as treatment of T-1a glottic carcinoma?
Vera Mahler et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2010)
Expression of metabolically targeted biomarkers in endometrial carcinoma
Heather Wahl et al.
GYNECOLOGIC ONCOLOGY (2010)
Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy
Ana P. D. Demasi et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2010)
Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy
Mark F. McCarty et al.
MEDICAL HYPOTHESES (2010)
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
John DeVincenzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx - a follow-up study
Bipin T. Varghese et al.
ACTA OTO-LARYNGOLOGICA (2009)
GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
Thomas Amann et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Radiotherapy in Larynx Squamous Cell Carcinoma is not Associated with an Increased Diagnosis of Second Primary Tumours
R. D. Farhadieh et al.
CLINICAL ONCOLOGY (2009)
Biomarkers in renal cell carcinoma
Barry B. McGuire et al.
CURRENT OPINION IN UROLOGY (2009)
Outcome of conservation surgery for laryngeal carcinoma: an 8-year trial
Bilge Tuna et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2009)
GLUT1 as a therapeutic target in hepatocellular carcinoma
Thomas Amann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
INHIBITION OF CELL PROLIFERATION AND GLUCOSE UPTAKE IN HUMAN LARYNGEAL CARCINOMA CELLS BY ANTISENSE OLIGONUCLEOTIDES AGAINST GLUCOSE TRANSPORTER-1
Shui-Hong Zhou et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: Present status and future prospects
B. S. Dwarakanath et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2009)
Expression and Correlation of Hypoxia-inducible Factor-1α, Vascular Endothelial Growth Factor and Microvessel Density in Experimental Rat Hepatocarcinogenesis
W. Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
The promises and pitfalls of RNA-interference-based therapeutics
Daniela Castanotto et al.
NATURE (2009)
Hypothesis: Using the Warburg effect against cancer by reducing glucose and providing lactate
Maarten W. N. Nijsten et al.
MEDICAL HYPOTHESES (2009)
Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography
Amir H. Khandani et al.
NUCLEAR MEDICINE COMMUNICATIONS (2009)
Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis
Mateja Legan et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Clinical Significance of FDG Single-Photon Emission Computed Tomography: Computed Tomography in the Diagnosis of Head and Neck Cancers and Study of Its Mechanism
Ling-Fa Li et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms
William A. Ahrens et al.
HUMAN PATHOLOGY (2008)
Aerobic glycolysis in cancers: Implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia
Morten Busk et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Overexpression of intrinsic hypoxia markers HIF1α and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy
M. L. Schrijivers et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions
Paola Parente et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Expression of glucose transporter-1 and-3 in the head and neck carcinoma - The correlation of the expression with the biological behaviors
Shuihong Zhou et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES (2008)
Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells
Laleh G. Melstrom et al.
PANCREAS (2008)
Rationale for adjuvant fatty acid therapy to prevent radiotherapy failure and tumor recurrence during early laryngeal squamous cell carcinoma
L. Louw et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Regulation of the Warburg effect in early-passage breast cancer cells
Ian F. Robey et al.
NEOPLASIA (2008)
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies
Andrew Evans et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Prognostic implications of glucose transporter protein-1 (Glut-1) overexpression in bone and soft-tissue sarcomas
Makoto Endo et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
Robert J. Gillies et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Biological correlates of FDG uptake in non-small cell lung cancer
Lioe-Fee de Geus-Oei et al.
LUNG CANCER (2007)
2-Deoxy-D-glucose combined with cisplatin, enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells
Andreart L. Simons et al.
CANCER RESEARCH (2007)
Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference
Darjus Tschaharganeh et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
The inhibitors of apoptosis (IAPs) as cancer targets
Allison M. Hunter et al.
APOPTOSIS (2007)
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
J Shen et al.
GENE THERAPY (2006)
Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway
CA Granville et al.
CLINICAL CANCER RESEARCH (2006)
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer
P Nix et al.
BRITISH JOURNAL OF CANCER (2005)
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
A Rarnanathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The prognostic value of the hypoxia markers CA IX and GLUT I and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy chemotherapy
H De Schutter et al.
BMC CANCER (2005)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression
JC Maher et al.
PANCREAS (2005)
Long-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone : studied by lognormal and Kaplan-Meier survival methods
P Tai et al.
BMC CANCER (2005)
Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study
M Tian et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary
T Kurokawa et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
IS Wood et al.
BRITISH JOURNAL OF NUTRITION (2003)
Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death
RL Aft et al.
BRITISH JOURNAL OF CANCER (2002)
Supraglottic carcinoma: Patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients
LV Johansen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma
MPM Stokkel et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 cells
CP Chen et al.
BIOCONJUGATE CHEMISTRY (2002)
Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells
TN Seagroves et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer
K Higashi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA
JYW Chan et al.
LIFE SCIENCES (2000)
Suppression of facilitative glucose transporter 1 mRNA call suppress tumor growth
Y Noguchi et al.
CANCER LETTERS (2000)
Share Paper
